After Brexit – practical implications for trade mark owners
Latest Insights
/Passle/6130aaa9400fb30e400b709a/MediaLibrary/Images/2024-05-16-11-37-11-800-6645efe75f1e870076120de2.png)
UPC: Does an acquired marketing authorisation indicate imminent infringement?
Zentiva, a Portuguese generics company, sought and was granted marketing authorisation for a generic form of Boehringer Ingelheim’s...
Read more
/Passle/6130aaa9400fb30e400b709a/SearchServiceImages/2025-07-17-09-43-24-366-6878c5bc2d1780b8749b2b15.jpg)
Oops-zempic? Novo Nordisk opens the door to early Ozempic generics in Canada
It has emerged that Novo Nordisk missed the payment of the maintenance (renewal) fee on their Canadian Ozempic patent, resulting in its...
Read more
/Passle/6130aaa9400fb30e400b709a/SearchServiceImages/2025-07-01-10-09-52-703-6863b3f0314be9321cfb9d33.jpg)
Neurotech patents in Europe: Part 3 - Sufficiency of Disclosure and the Plausibility Problem
Patent laws generally set out a sufficiency requirement that patent applications must satisfy in order to be granted and remain valid...
Read more